Trial country

AustraliaAustriaBelgiumCanadaChinaCzech RepublicDenmarkEgyptFinlandFranceGermanyIsraelItalyJapanMexicoNetherlandsNew ZealandNorwayPolandRussiaSingaporeSouth KoreaSpainSwedenSwitzerlandTaiwanUKUSA Multi-country

Principal investigator

Disease category

Cancer diseasesCardiovascular diseasesGene markingHealthy volunteersInfectious diseasesMonogenic diseasesNeurological diseasesOcular diseases Others

Indication

Clinical phase

II/IIIIII/IIIIII

Trial status

OpenClosedWithdrawnOn clinical holdConditional approvalNever initiatedCanceledUnder reviewSubmission not completeDuplicate Submission of US-697

Year approved/initiated

1989199019911992199319941995199619971998199920002001200220032004200520062007